Elanco (ELAN) GC Shiv O'Neill reports tax-withholding share disposition

Q: Was the Elanco (ELAN) insider transaction an open-market sale?

No. The Form 4 identifies the transaction as a tax-withholding disposition under code F , meaning shares were withheld to satisfy tax obligations, not sold in an open-market transaction by Shiv O'Neill.

Q: How many Elanco (ELAN) shares did Shiv O'Neill hold after the Form 4 transaction?

Following the reported tax-withholding disposition, Shiv O'Neill was shown as directly owning 83,834 shares of Elanco common stock, according to the Form 4, which lists total shares beneficially owned after the transaction.

Q: What was the price used in Shiv O'Neill’s Elanco (ELAN) tax-withholding transaction?

The Form 4 shows the tax-withholding disposition of 4,738 Elanco common shares at a price of $24.88 per share , which is the value used to calculate the shares withheld for tax purposes.

Q: What role does Shiv O'Neill hold at Elanco (ELAN) in the Form 4 filing?

In the Form 4, Shiv O'Neill is identified as an officer of Elanco Animal Health Inc., serving as General Counsel and Corporate Secretary , and is the reporting person for the disclosed tax-withholding share disposition.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Elanco Animal Health Inc general counsel and corporate secretary Shiv O'Neill reported a Form 4 transaction involving company common stock. On March 3, 2026, O'Neill had 4,738 shares disposed of in a tax-withholding disposition at $24.88 per share, leaving 83,834 shares of directly owned common stock reported after the transaction. This disposition reflects shares withheld to cover tax obligations rather than an open-market sale.

Insider Trade Summary

Net Seller: 4,738 shares

Net Sell 1 txn

Insider O'Neill Shiv

Role GC AND CORP SEC

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	4,738	$24.88	$118K

Holdings After Transaction: Common Stock — 83,834 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/05/2026 - 04:19 PM

FAQ

What insider transaction did Elanco (ELAN) report for Shiv O'Neill?

Elanco reported that general counsel and corporate secretary Shiv O'Neill had 4,738 common shares disposed of in a tax-withholding transaction at $24.88 per share, as disclosed in a Form 4 insider filing.

Was the Elanco (ELAN) insider transaction an open-market sale?

No. The Form 4 identifies the transaction as a tax-withholding disposition under code F, meaning shares were withheld to satisfy tax obligations, not sold in an open-market transaction by Shiv O'Neill.

How many Elanco (ELAN) shares did Shiv O'Neill hold after the Form 4 transaction?

Following the reported tax-withholding disposition, Shiv O'Neill was shown as directly owning 83,834 shares of Elanco common stock, according to the Form 4, which lists total shares beneficially owned after the transaction.

What was the price used in Shiv O'Neill’s Elanco (ELAN) tax-withholding transaction?

The Form 4 shows the tax-withholding disposition of 4,738 Elanco common shares at a price of $24.88 per share, which is the value used to calculate the shares withheld for tax purposes.

What role does Shiv O'Neill hold at Elanco (ELAN) in the Form 4 filing?

In the Form 4, Shiv O'Neill is identified as an officer of Elanco Animal Health Inc., serving as General Counsel and Corporate Secretary, and is the reporting person for the disclosed tax-withholding share disposition.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Neill Shiv

(Last)

(First)

(Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS

46221

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	GC AND CORP SEC

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2026		F		4,738	D	$24.88	83,834	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Amy C. Seidel, as Attorney-in-Fact for Shiv O'Neill	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR